NKCx Histopathological outcome* within 12 months after cervix cytology in 2018
631 Jämtland

  Benign CIN1 CIN2 CIN3 AIS Cancer Other PAD missing Total
Cytology Count Pct Count Pct Count Pct Count Pct Antal Andel Count Pct Count Pct Count Pct Count Pct
Benign sample 39 0.7% . . . . 1 0.0% . . . . . . 5721 99.3% 5761 100.0%
ASCUS 44 18.8% 32 13.7% 1 0.4% 35 15.0% . . . . 2 0.9% 120 51.3% 234 100.0%
CIN1 18 22.8% 23 29.1% . . 12 15.2% . . . . 1 1.3% 25 31.6% 79 100.0%
Atypical glandular cells/AGC 3 33.3% . . . . 3 33.3% 1 11.1% 1 11.1% 1 11.1% . . 9 100.0%
Unclear atypia 5 50.0% 2 20.0% . . . . 1 10.0% . . . . 2 20.0% 10 100.0%
ASC-H 3 15.0% 2 10.0% . . 14 70.0% . . . . . . 1 5.0% 20 100.0%
CIN3 1 3.3% 1 3.3% . . 27 90.0% . . 1 3.3% . . . . 30 100.0%
Adenocarcinoma 1 100.0% . . . . . . . . . . . . . . 1 100.0%
Total 114 1.9% 60 1.0% 1 0.0% 92 1.5% 2 0.0% 2 0.0% 4 0.1% 5869 95.5% 6144 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes
in the category
Cancer:
M80703